Patented Pharmaceutical Reconstitutable Sustained Release Suspension
暂无分享,去创建一个
[1] S. H. Jaber,et al. Formulation of Azithromycin Suspension as an Oral Dosage Form , 2017, Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512).
[2] A. Chenthilnathan,et al. Formulation development and evaluation of taste masked Cefuroxime axetil dry suspension , 2013 .
[3] N. G. R. Rao,et al. Overview on Controlled Release Dosage Form , 2013 .
[4] S. Bhaskaran,et al. Dry Suspension Formulation of Taste Masked Antibiotic Drug for Pediatric Use , 2012 .
[5] A. Bozkır,et al. Formulation and evaluation of reconstitutable suspensions containing ibuprofen-loaded Eudragit microspheres. , 2011, Acta poloniae pharmaceutica.
[6] 雷蒙·帕森斯. Use PTEN-Long leader sequence transmembrane delivery of molecules , 2011 .
[7] R. Doijad,et al. An Approch For Development Of Oral Sustained Release Suspension , 2011 .
[8] 라지브 고칼레,et al. Stable nanoparticulate drug suspension , 2010 .
[9] Asgar Ali,et al. FORMULATION AND IN VITRO EVALUATION OF READYUSE SUSPENSION OF AMPIILLIN TRIHYDRATE , 2010 .
[10] R. Mutahar,et al. Formulation and stability study of palatable norfloxacin dry syrup: comparison among different preparation methods , 2010 .
[11] 拉米雷斯 莫内塔 罗德里格·伊凡. Immunosuppressive macrolide powder for oral suspension , 2009 .
[12] マーフィー,エドウィン・カレン,et al. Injectable meclizine formulations and methods , 2008 .
[13] 배어 한스,et al. Ph-dependent controlled release pharmaceutical opioid composition with resistance against the influence of ethanol , 2008 .
[14] J. Emami,et al. Preparation and evaluation of a liquid sustained-release drug delivery system for theophylline using spray-drying technique , 2008 .
[15] T. Mickle. POLAR HYDROPHILIC PRODRUGS OF AMPHETAMINE AND OTHER STIMULANTS AND PROCESSES FOR MAKING AND USING THE SAME RELATED APPLICATIONS , 2008 .
[16] F. Guimberteau,et al. microparticulate oral pharmaceutical form anti-misuse , 2005 .
[17] D·B·赫克,et al. Sulfoalkyl ether cyclodextrin compositions and methods for preparing , 2005 .
[18] P. Linko,et al. Microencapsulation of l-menthol by spray drying and its release characteristics , 2005 .
[19] 아테프 에이. 가예드,et al. Taste-masked formulations containing sertraline and sulfoalkyl ether cyclodextrin , 2005 .
[20] 모쉐 게롤드엘.,et al. Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid prepared from a unit dose suspension , 2004 .
[21] Яков Яковлевич Махмудов,et al. Method for treating chronic abacterial prostatitis/syndrome of chronic noninflammatory pelvic pain , 2003 .
[22] F. Guimberteau,et al. oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release principle (s) active (s) , 2002 .
[23] E. Doelker,et al. Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage forms , 1992 .